Oppenheimer Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,644
| Closed | -$1.11M | – | 1188 |
|
|
2022
Q2 | $1.11M | Sell |
7,644
-309
| -4% | -$45K | 0.02% | 643 |
|
|
2022
Q1 | $943K | Sell |
7,953
-20
| -0.3% | -$2.37K | 0.01% | 757 |
|
|
2021
Q4 | $1.1M | Buy |
7,973
+5,741
| +257% | +$791K | 0.01% | 752 |
|
|
2021
Q3 | $310K | Sell |
2,232
-66
| -3% | -$9.17K | ﹤0.01% | 1049 |
|
|
2021
Q2 | $223K | Buy |
+2,298
| New | +$223K | ﹤0.01% | 1124 |
|
|
2021
Q1 | – | Sell |
-2,531
| Closed | -$217K | – | 1233 |
|
|
2020
Q4 | $217K | Buy |
+2,531
| New | +$217K | ﹤0.01% | 1060 |
|
|
2020
Q2 | – | Sell |
-2,681
| Closed | -$91K | – | 1538 |
|
|
2020
Q1 | $91K | Sell |
2,681
-144
| -5% | -$4.89K | ﹤0.01% | 1126 |
|
|
2019
Q4 | $154K | Sell |
2,825
-19
| -0.7% | -$1.04K | ﹤0.01% | 1111 |
|
|
2019
Q3 | $119K | Buy |
+2,844
| New | +$119K | ﹤0.01% | 1146 |
|